Browsing by Author Karavasilis, V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 19 to 31 of 31 < previous 
TitleAuthor(s)Issue date???itemlist.???
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation studyBriasoulis, E.; Karavasilis, V.; Tzamakou, E.; Haidou, C.; Piperidou, C.; Pavlidis, N.24-Nov-2015-
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case studyPappas, P.; Karavasilis, V.; Briasoulis, E.; Pavlidis, N.; Marselos, M.24-Nov-2015-
PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsSainis, I.; Vareli, K.; Karavasilis, V.; Briasoulis, E.24-Nov-2015-
Proteolysis and angiogenesis in cancer of unknown primary. A clinicopathological studyKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kalofonos, H.; Fountzilas, G.; Kitsou, E.; Fotsis, T.; Pavlidis, N.24-Nov-2015-
Pseudomonas fluorescens infections in clinical practicePappas, G.; Karavasilis, V.; Christou, L.; Tsianos, E. V.24-Nov-2015-
Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvisKatsanos, K. H.; Briasoulis, E.; Tsekeris, P.; Batistatou, A.; Bai, M.; Tolis, C.; Capizzello, A.; Panelos, I.; Karavasilis, V.; Christodoulou, D.; Tsianos, E. V.24-Nov-2015-
Revisiting bleomycin from pathophysiology to safe clinical useFroudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E.24-Nov-2015-
Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactionsBriasoulis, E.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Syndrome of inappropriate antidiuretic hormone secretion due to recurrent oral cancerDanielides, V.; Milionis, H. J.; Karavasilis, V.; Briasoulis, E.; Elisaf, M. S.24-Nov-2015-
Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapyKostopoulos, I.; Karavasilis, V.; Karina, M.; Bobos, M.; Xiros, N.; Pentheroudakis, G.; Kafiri, G.; Papakostas, P.; Vrettou, E.; Fountzilas, G.24-Nov-2015-
Visual tracking using the Earth Mover's Distance between Gaussian mixtures and Kalman filteringKaravasilis, V.; Nikou, C.; Likas, A.24-Nov-2015-
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administrationBriasoulis, E.; Karavasilis, V.; Anastasopoulos, D.; Tzamakou, E.; Fountzilas, G.; Rammou, D.; Kostadima, V.; Pavlidis, N.24-Nov-2015-
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumorsBriasoulis, E.; Pentheroudakis, G.; Karavasilis, V.; Tzamakou, E.; Rammou, D.; Pavlidis, N.24-Nov-2015-